Enthuse for PERUSE: when clinical judgment overcomes regulatory boundaries von Guarneri, V.

Volltext

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials von Dieci, M.V., Mathieu, M.C., Guarneri, V., Conte, P., Delaloge, S., Andre, F., Goubar, A.

Volltext

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study von Dieci, M.V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M.C., Delaloge, S., Curigliano, G., Andre, F.

Volltext

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study von Dieci, M.V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M.C., Delaloge, S., Curigliano, G., Andre, F.

Volltext

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis von Dieci, M.V., Barbieri, E., Piacentini, F., Ficarra, G., Bettelli, S., Dominici, M., Conte, P.F., Guarneri, V.

Volltext

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients von Guarneri, V., Dieci, M.V., Barbieri, E., Piacentini, F., Omarini, C., Ficarra, G., Bettelli, S., Conte, P.F.

Volltext

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges von Pavan, A, Attili, I, Pasello, G, Guarneri, V, Conte, P F, Bonanno, L

Volltext

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study von Guarneri, V., Dieci, M.V., Bisagni, G., Frassoldati, A., Bianchi, G.V., De Salvo, G.L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C.A., Moretti, G., Griguolo, G., Vicini, R., Prat, A., Conte, P.F.

Volltext

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective tria... von Loibl, S., Majewski, I., Guarneri, V., Nekljudova, V., Holmes, E., Bria, E., Denkert, C., Schem, C., Sotiriou, C., Loi, S., Untch, M., Conte, P., Bernards, R., Piccart, M., von Minckwitz, G., Baselga, J.

Volltext

Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival von Miglietta, F., Bottosso, M., Griguolo, G., Dieci, M.V., Guarneri, V.

Volltext

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial von Dieci, M.V., Prat, A., Tagliafico, E., Paré, L., Ficarra, G., Bisagni, G., Piacentini, F., Generali, D.G., Conte, P., Guarneri, V.

Volltext

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes von Bonanno, L., Pavan, A., Dieci, M.V., Di Liso, E., Schiavon, M., Comacchio, G., Attili, I., Pasello, G., Calabrese, F., Rea, F., Favaretto, A., Rugge, M., Guarneri, V., Fassan, M., Conte, P.F.

Volltext

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer von Dieci, M.V., Conte, P., Bisagni, G., Brandes, A.A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S., D’Amico, R., Guarneri, V.

Volltext

Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey von Banerjee, S., Califano, R., Corral, J., de Azambuja, E., De Mattos-Arruda, L., Guarneri, V., Hutka, M., Jordan, K., Martinelli, E., Mountzios, G., Ozturk, M.A., Petrova, M., Postel-Vinay, S., Preusser, M., Qvortrup, C., Volkov, M.N.M., Tabernero, J., Olmos, D., Strijbos, M.H.

Volltext

Anthracyclines in the treatment of patients with early breast cancer von Guarneri, V, de Azambuja, E

Volltext

Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials von Guarneri, V., Griguolo, G., Miglietta, F., Conte, P.F., Dieci, M.V., Girardi, F.

Volltext

Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review von Miglietta, F., Fabi, A., Generali, D., Dieci, M.V., Arpino, G., Bianchini, G., Cinieri, S., Conte, P.F., Curigliano, G., De Laurentiis, M., Del Mastro, L., De Placido, S., Gennari, A., Puglisi, F., Zambelli, A., Perrone, F., Guarneri, V.

Volltext

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials von Dieci, M. V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G., Goubar, A., Ficarra, G., Griguolo, G., Conte, Pierfranco, Guarneri, V.

Volltext

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative br... von Dent, R., André, F., Gonçalves, A., Martin, M., Schmid, P., Schütz, F., Kümmel, S., Swain, S.M., Bilici, A., Loirat, D., Villalobos Valencia, R., Im, S.-A., Park, Y.H., De Laurentis, M., Colleoni, M., Guarneri, V., Bianchini, G., Li, H., Kirchmayer Machackova, Z., Mouta, J., Deurloo, R., Gan, X., Fan, M., Mani, A., Swat, A., Cortés, J.

Volltext

Corrigendum to “Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review”... von Miglietta, F., Fabi, A., Generali, D., Dieci, M.V., Arpino, G., Bianchini, G., Cinieri, S., Conte, P.F., Curigliano, G., De Laurentiis, M., Del Mastro, L., De Placido, S., Gennari, A., Puglisi, F., Zambelli, A., Perrone, F., Guarneri, V.

Volltext